A heritage more than 130 years strong: company founded on May 10,
1876
Approximately 41,350 employees* worldwide
Approximately 7,980 employees engaged in research and development
Clinical research conducted in more than 50 countries
Research and development facilities located in 9 countries
Manufacturing plants located in 13 countries
Products marketed in 143 countries
Introduced:
Byetta®, a first in a new class of medicines known as incretin mimetics to treat type 2 diabetes
Cymbalta®, for major depressive disorder and diabetic peripheral neuropathic pain
Alimta®, the first and only chemotherapy regimen approved by
the FDA to treat patients with malignant pleural mesothelioma who
are not candidates for surgery
Symbyax®, for bipolar depression
Cialis®, a distinctive new treatment for erectile dysfunction from the Lilly ICOS joint venture
Strattera®, the first FDA-approved nonstimulant, noncontrolled medication for the treatment of attention-deficit hyperactivity disorder in children, adolescents, and adults
Forteo®, first-in-class medicine for osteoporosis patients that stimulates new bone formation
Xigris®, the first treatment approved for adult severe-sepsis
patients at a high risk of death
Evista®, the first in a new class of drugs for the prevention and treatment of postmenopausal osteoporosis
Zyprexa®, breakthrough product for schizophrenia and acute mania
associated with bipolar disorder
Humalog®, a fast-acting insulin product
Gemzar®, for pancreatic and non-small-cell lung cancer, one of the world's best-selling oncology agents
Humatrope®, therapy for growth hormone deficiency
Prozac®, which revolutionized the treatment of depression
Humulin®, human insulin, the first human-health-care product created by biotechnology
Ceclor®, which became the world's top-selling oral antibiotic
Iletin®, the first commercially available insulin product, in 1923
Established:
A pioneering initiative to treat multi-drug resistant tuberculosis (MDR-TB),
one of the deadliest public health threats in the world. In collaboration
with the World Health Organization (WHO), the U.S. Department of Health and
Human Services Centers for Disease Control and Prevention, Brigham and
Women's Hospitals of Harvard Medical School, and Purdue University,
Lilly is providing low-cost antibiotics, training for international
medical personnel, and technology to enable the manufacture of products
for treatment in China, India, and South Africa.
Named:
One of the Best Companies for Working Mothers (in the top 10 for
the seventh time in 11 years) by Working Mother magazine
Highlights
Headquarters: Indianapolis, Indiana, U.S.A
Employees (as of 3/31/08)
Indianapolis
Indiana (excluding Indianapolis)
U.S. (excluding Indiana)
Outside U.S.
Worldwide total
Products sold
12,584
2,208
5,366
20,070
40,217
143 countries
Financials-2006
(dollars in millions, except per-share data)
Net sales
Net income-as reported
Earnings per share-as reported
Dividends paid per share
Capital expenditures
Products|
Highlights